NQGCX
Price
$35.24
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
TEDRX
Price
$31.75
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

NQGCX vs TEDRX

Header iconNQGCX vs TEDRX Comparison
Open Charts NQGCX vs TEDRXBanner chart's image
Nuveen Global Equity Income C
Price$35.24
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Franklin Mutual Global Discovery R
Price$31.75
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NQGCX vs TEDRX Comparison Chart
Loading...
VS
NQGCX vs. TEDRX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQGCX is a Buy and TEDRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
TEDRX has more cash in the bank: 9.44B vs. NQGCX (136M). NQGCX pays higher dividends than TEDRX: NQGCX (1.60) vs TEDRX (1.05). NQGCX was incepted earlier than TEDRX: NQGCX (15 years) vs TEDRX (23 years). TEDRX is a more actively managed with annual turnover of: 35.47 vs. NQGCX (29.00). TEDRX has a lower initial minimum investment than NQGCX: TEDRX (1000) vs NQGCX (3000). NQGCX annual gain was more profitable for investors over the last year : 18.49 vs. TEDRX (8.26). NQGCX return over 5 years is better than : 48.79 vs. TEDRX (8.70).
NQGCXTEDRXNQGCX / TEDRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD11.8397.867150%
Front LoadN/AN/A-
Min. Initial Investment30001000300%
Min. Initial Investment IRAN/AN/A-
Net Assets136M9.44B1%
Annual Yield % from dividends1.601.05152%
Returns for 1 year18.498.26224%
Returns for 3 years19.531.571,245%
Returns for 5 years48.798.70561%
Returns for 10 years44.26-3.79-1,169%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIND10.620.47
+4.63%
Lindblad Expeditions Holdings
UTK.X0.0449510.001103
+2.52%
xMoney cryptocurrency
AKRO26.960.32
+1.20%
Akero Therapeutics
SF89.980.39
+0.44%
Stifel Financial Corp
BCAB1.66-0.02
-1.19%
BioAtla